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1. There is a dramatic downregulation of a-actin and vimentin microfilaments in athero- 
sclerotic plaque. 
2. OxLDL markedly downregulates VSMC a-actin and vimentin expression via a PPARy 
and ~38 MAPK Independent pathway. OxLDL regulation of VSMC cytoskeletal pro- 
teins may play a critical role in afherogenesis through alterations In cell motility, differ- 
entiation and growth. 
1200-l 38 Intravascular Detection of lnflammed Atherosclerotic 
Plaques With a Novel Macrophage-Targeted 
Fluorescent Photodynamic Compound 
Ahmed Tawakol, Alan Fischman, Henry Gewirtz, James E. Muller, Thomas Brady, 
Michael Hamblin, Mass General Hospital, Boston, MA 
Background: Vulnerable plaques contain abundant macrophages. We developed a 
novel photodynamic agent, chlorin, conjugated with maleylated albumin, (ce6-mal-alb) 
that concentrates in macrophage-rich plaques and has a high fluorescent yield. As such, 
we tested hypothesis that experimental atherosclerotic lesions (ATHERO) can be 
detected using ce6-mal-alb and an intravascular fluorescence spectroscopy catheter. 
Methods: ATHERO were induced in New Zealand rabbits by infradiaphragmatic aortic 
balloon-injury followed by high cholesterol diet. At IO weeks, ce6-mal-alb was adminis- 
tered to 7 atherosclerotic and 7 control animals. 24 hours later, aortic uptake of the ce6- 
mal-alb uptake was measured in situ, using an intravascular fluorescence spectroscopy 
catheter. Thereafter, the aortas were excised and dissolved in NaOH/SDS for spectroflu- 
orimetric determination of ce6 content. 
Results: Intravascular measurements of ce6-mal-alb fluorescence were higher in 
ATHERO vs. non-athero segments, (8.8i4.8 vs. 2.2k2.2 X103AU, P<O.OOl, figure). Fur- 
ther, ce6-mal-alb concentration was higher within the ATHERO aortas (5.2t3.2 vs. 
1.9+1.2, ce6 fluorescencelgm tissue x IOs, p=<O.Ol). Conclusion: CeG-mal-alb can be 
employed for intravascular characterization of atherosclerotic plaques. Because this 
novel PDT compound is selectively toxic to macrophages when light-activated, this agent 
may be useful for both the detection and therapeutic modification of macrophage-rich 
plaques. 
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1200-l 39 Endogenous Free Radical Generating Sources Are 
Involved in Smoking-Mediated Dysfunction of Nitric 
Oxide Biosynthesis in Human Coronary Artery 
Endothelial Cells: An In Vitro Demonstration 
Sudhesh K. Srivastava, Rajat S. Barua, Dhanonjoy C. Saha, Lesley-Jane Eales- 
Reynolds, Mary C. DeVoe, John A. Ambrose, Saint Vincent Catholic Medical Centers of 
New York, New York, NY, School of Biomedical and Life Sciences, University of Surrey, 
Guildford, United Kingdom 
Backgromd We have previously demonstrated that cigarette smoking alters NO bio- 
synthesis by reducing NO availability and eNOS activity while increasing eNOS protein 
expression. Although oxidative stress has been proposed as the leading mechanism for 
these changes, the source of free radicals is unclear. Cigarette smoke contains high lev- 
els of free radicals. However, free radicals potentially arise from endogenous sources as 
well. This study investigated the role of endogenous free radical generating sources in 
smoking-related dysfunctional NO biosynthesis in human coronary artery endothelial 
cells (HCAECs). 
Methods and Results Confluent (-85%) monolayers of HCAECs were incubated with 
serum from 6 nonsmokers and 8 smokers for 12 hours with or without the addition of 
either IOOuM LNMMA, 30uM apocyamn (NADPH oxidase inhibitor), 1OOuM allopurinol 
(xanthine oxidase inhlbitor) or 2uM rotenone lmitochondrial electron transporl chain 
(METC) inhibitor]. Following incubation, NO levels and eNOS protein expression were 
measured from the same culture by standard techniques. HCAECs incubated with smok- 
ers’ serum alone showed significantly lower NO level (O.OZ+O.Olversus 0.13*0.02 uM/pg 
eNOS/mg total protein, P<O.O07) and higher eNOS expression (P<O.OOS) compared to 
nonsmokers. In smokers, only allopurinol (0.04*0.01 uM/pg eNOS/mg total protein) or 
rotenone (0.06*0.01 uM/pg eNOS/mg total protein) treatment significantly +0.05) 
improved NO availabillty. However, levels were still lower compared to nonsmokers 
(P<O.O5). Interestingly, when smokers’ serum was treated with combined rotenone. 
allopurinol and 20uM tetrahydrobiopterin (an eNOS cofactor) the NO level, eNOS 
expression and eNOS activity normalized to that of nonsmokers. 
Conclusions To our knowledge this is the first demonstration that endogenous free 
radical generators such as xanthine oxidase, the METC and eNOS contribute to smok- 
ing-mediated dysfunction of NO biosynthesis. 
1200-140 Synergistic Effect of Urotensin II With Serotonin on 
Vascular Smooth Muscle Cell Proliferation 
Takuva Watanabe, Takashi Katagiri, Rajbabu Pakala, Claude R. Benedict, Showa 
University School of Medicine, Tokyo, Japan, University of Texas-Houston Medical 
School, Houston, TX 
Background: Urotensin II (U-II), the most potent vasoconstrictor known to date, and sero- 
tonin (5-HT) have been recently shown to play an important role in pulmonary hyperten- 
sion. However, little is known about the effect of U-II and its interaction with 5.HT on 
vascular smooth muscle cell (VSMC) proliferation. We assessed the interaction between 
U-II and 5.HT in inducing VSMC proliferation. 
Methods: Growth-arrested rabbit VSMCs were incubated in serum-free medium with dif- 
ferent concentrations of U-II and 5-HT. VSMC proliferation was examined by the 
increase in [SHlthymidine incorporation into cellular DNA and cell number. 
Results: U-II or 5.HT induced [3H]thymidlne incorporation in a concentration-dependent 
manner with a maximal effect at a concentration of 50 nanoM (I 61%) or 50 microM 
(205%), respectively. When added together, low concentrations of U-II (50 nanoM) and 
5-HT (1 microM) interacted synergistically in inducing [SH]thymidine incorporation 
(382%). These effects on [SH]thymidine incorporatlon were paralleled by an increase in 
cell number. The G-protein inactivator GDP-beta-S (100 microM), protein kinase C (PKC) 
inhibitor Ro31-8220 (0.1 microM), c-Src tyrosine kinase inhibitor PP2 (I microM), and 
mitogen-activated protein kinase (MAPK) kinase inhibitor PD098059 (IO microM) signifi- 
cantly inhibited the mitogenic effects of U-II and 5-HT and also their interaction in induc- 
ing [3H]thymidine incorporabon. 
Conclusion: Our results suggest that U-II and 5-HT may induce the synergistic interaction 
in inducing VSMC proliferation via a G-protein-coupled receptor/PKClc-Src tyrosine 
klnase/MAPK pathway, thtis contributing to the relatively rapid development of athero- 
sclerosis in hypertensive vascular disease. 
1200-141 Systemic Inflammation: Independent Predictor of 
Contrast Induced Nephropathy 
Harish R. Chandra, Peter Kim, James A. Goldstein, Mehrdad H. Sadeghi, William W. 
O’Neill, William Beaumont Hospital, Royal Oak, MI 
Background: Recent observations demonstrate that systemic inflammation may exert 
adverse influence throughout the vascular bed. This study was designed to determine 
whether there is a relationship between the presence and magnitude of systemic inflam- 
mation and contrast induced nephropathy in patients undergoing coronary angiography. 
Methods: In 244 patients undergoing coronary angiography we analyzed the association 
between systemic markers of inflammation (high sensitivity C-reactive protein, CRP) and 
contrast Induced nephropathy (GIN) defined as decrease in creatinine clearance (CC) of 
al least 25 cclmin. Univariate and multivariate analysis were performed. 
Results: Mean age of the patients was 62+13 yrs and 61% we males. Baseline CC was 
89 cclmin. 82% underwent angiography for acute coronary syndrome. 8% developed 
CIN following the angiography. 2% of the patients in the first tertile of CRP develped CIN 
compared to 12% in second and 13% in the third tertile of CRP, p=O.O3. On multivariate 
analysis higher CRP tertile was an independent predictor of CIN (OR 2.8, p=O.OZ) along 
with use of intra-aortic balloon pump (OR=9.3, p=O.O4) and baseline creatinine clearance 
(OR=1.04, p<O.OOOl). 
Conclusion: These findings demonstrate a strong association between the presence and 
magnitude of systemic inflammation and development of contrast induced nephropathy. 
1200-l 42 Stabilization of Plaque Size Accompanied by a Time 
Dependent Decrease in Activated Macrophage Content 
After Vascular Injury in the Apolipoprotein-E Null 
Mouse 
Christopher J. Davis, Joshua J. Fischer, John M. Sanders, Daniel K. Bennett, Ian J. 
Sarembock, University of Virginia Health System, Charlottesville, VA 
Background: Apolipoprotein-E knockout (ApoE’) mouse models have been used to 
study atherosclerosis and responses to vascular injury. Wire injury of the carotid artery 
results in characteristic neointima formation 28 days after injury. The purpose of this 
study was to characterize plaque size and cellular content at 2 and 3 months after carotid 
injury to identify changes in lesion progression. 
Methods: Sixteen female ApoE-‘- mice were fed a Western diet for one week prior to 
wire denudation of the left common carotid artery and continued on the atherogenic diet 
for 4 weeks. After 4 weeks, they were fed a chow diet until sacrifice. Mice were eutha- 
nized at 2 months (n=8) and 3 months (n=8) after injuty and fasting blood was taken for 
glucose and cholesterol measurements. Vessels were harvested and paraffin embedded 
for morphology and immunocytochemistry. The results were compared to 1 month histor- 
ical controls. 
Results: At 1 month, plaque size was 30,500 * 5,300 pm2 , macrophage content was 
21+ 5 %. and cholesterol level was 1170 r 210 mg/dl. At 2 and 3 months, neolntimal 
areas were not statistically different (35,177 * 6,789pd vs. 29.196 * 7,31 2pm2 respec- 
tively) and similar to the 1 month group. The presence of activated macrophages in the 
neointima was significantly higher at 2 months compared to 3 months (26.2 f 5.7 % Vs 
4.2 * 1.5 %. p = ,002). There were no significant differences in mean glucose and choles- 
terol levels at 2 and 3 months (107 * 7 vs. 108 * 11 mg/dl and 427 * 20 vs. 435 * 35 mg/ 
dl respectively). 
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Conclusions: This study suggests that mean plaque size stabilizes at 4 weeks after 
carotid injury with no further increase at later time points. Furthermore, there appears to 
be a time dependent decrease in activated macrophages in the neointima. Potential 
mechanisms for this observatron are currently being investigated. 
X-gal staining (pfnvn2) 
P-gal activity (IUIpg 
proteinlmin) 
Ad5 RAd36 AdCPP- AdI-PREP- p 
lacz I.%.? IaCz (ANOVA) 
1519 462 1915 i507 16361 +4483 <O.OOOl 
*503 *I81 
0.05 0.11 0.07 r0.02 2.05 *1.46 <0.006 
*0.02 eO.06 
1200-143 Altered AP-IIRef-1 Redox Pathway in iNOS Deficient 
Vascular Smooth Muscle Cells: A Novel Involvement of 
iNOS in Cellular Signaling 
Kuang-Yuh Chyu, Xiaoning Zhao. Paul C. Dimavuaa, Bojan Cercek, Predimsn K. Shah, 
Cedars-Sinai Medical Center, Los Angeles, CA 
Background: We previously showed injury-induced medial proliferation and neointimal 
formation in carotid arteries of inducible nitric oxide synthase knockout (iNOS KO) mice 
were significantly less compared to wild type (WT). iNOS is a source of reactive oxygen 
species, which could modulate cellular growth and redox signaling molecules such es the 
AP-IlRef-llthioredoxln pathway. 
Hypothesis: SMC deficient in iNOS have altered redox sensitive AP-l/Ref-1 signaling 
pathway and reduced proliferative response to serum stimulation. 
Methods: Confluent aortic SMC isolated from iNOS KO and WT mice were stimulated to 
proliferate with 20% serum media after 48 hours of quiescence. Cell cycling by FACS 
analysis and nuclear PCNA and thioredoxin by Western blot was characterized 24 hours 
after stimulation. The following assays were performed 30 minutes after stimulation: AP- 
I DNA binding activity by gel-shin assay; cJun mRNA by semi-quantitative RT-PCR and 
cJun and Ref.1 expression by Western blotllng. 
Results: Cell cycle analysis showed significantly more iNOS KO cells remamed in the 
GO/G1 phase and less in S phase aHer 24 hours of serum stimulation. cJun and Ref.1 
expression and AP-1 activity were also less in iNOS KO SMC (Table). Thioredoxin 
expression was also less in iNOS KO cells. 
Conclusion: Our data demonstrated reduced proliferative response and altered AP-I/ 
Ref-1 signaling pathway in iNOS KO SMC, implying a novel signaling mechanism for 
iNOS involvement in modulating SMC proliferation. 
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PCNA. AP-I, nuclear c-Jun and c-jun mRNA are expressed as fold change relative to 
unstimulated cells; Ref.1 is expressed as relative densitometric units; *p<O.O5. Each 
experiment was repeated at least 3 times 
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1201-117 A Combination of Transcriptional Regulatory Elements 
Increases Transgene Expression 40-Fold in Porcine 
Coronary Arteries 
Glare E. Appleby, Paul A. Kingston, Anne David, Anthony M. Heagerty, University of 
Medicine, Manchester, United Kingdom 
SMC are relatively refractory to adenovirus mediated gene transfer, due in part to poor 
transgene expression, even from powerful viral promoters. The murine cytomegalovirus 
promoter (MIEmCMV) significantly improves transgene expression in SMC compared to 
the widely used human CMV promoter (MIEhCMV). Inclusion of the Woodchuck Hepati- 
tis Virus Post Transcriptional Regulatory Element (WPRE) and a fragment of the rabbit 
smooth muscle myosm heavy chain promoter (RE) further increases expression of /acZ 
=5 foldin vitro. We hypothesised that this combination would significantly increase trans- 
gene expression in viva. Methods: Porcine coronary arteries randomly received Pxl@iu 
of the followlng vectors in 3OOpl of vehicle (n=4/group) via an Infiltrator? 
1. Ad5-/acZ: MlEhCMV 
2. RAd36: MlEmCMV 
3. Ad5PP-/acZ: MIEmCMV, WPRi 
4. Add-PREP-/acZ RE, MIEmCMV, WPRE. 
After 72 hours bgalactosidase expression and activity was quantified. Results: Ad5- 
PREP-/acZ induced 40 times greater P-gal activity than Ad5-/acZ (~~0.05) and greater 
activity than the other MlEmCMV based vectors (both pcO.01). X-gal staining was 7-35 
fold greater in Ad5-PREP-/acZinfected vessels (all pcO.001). Conclusion: Inclusion of 
WPRE and RE within the cassette of a recombinant adenovirus vector regulated by 
MlEmCMV substantially improves transgene expression in porcine coronary arteries. By 
maximizing expression or allowing use of lower virus doses this has important Implica- 
tions for successful gene therapy in the vasculature. 
1201-118 Blockade of TGF-Beta by Catheter-Based Gene Transfer 
of a Soluble TGF-Beta Type II Receptor Inhibits 
Neointima in a Porcine Coronary Artery After Stenting 
Ick-Mo Chunq Hikaru Ueno, Donghoon Choi, Yangsoo Jang, Gil-Ja Shin, Youngmi K. 
Pak, Junwoo Kim, Chan Park, Ewha Women’s University, Seoul, South Korea, University 
of OccupatIonal and Environmental Health, Kitakyusyu, Japan 
Background: Enhanced extracellular matrix (ECM) accumulation is an important finding 
in porcine as well as in human coronary stent restenotic tissue, and TGFQ, implicated in 
ECM formation, is expressed abundantly in these tissue. We assessed the hypothesis 
that blockade of TGFQ by local delivery of an adenovirus expressing a soluble form of 
TGF-P type II receptor (AdTP_ExR) inhibits stent-induced neointima in porcine coronary 
arteries. 
Methods: Two remote coronary arterial segments (n=20) per each pig were randomized 
to receive 1x10’ pfu of either AdTeExR or adenovirus expressing !3-galactosidase 
(AdLacZ) using an infiltrator. A stent (n=20) was deployed aHer gene transfer in each 
segment in IO pigs. Localized expression of transgene was confirmed by both reverse 
transcription-PCR and immunohistochemistry. Computer-based morphometric assess- 
ment was performed in stented arteries at 4 weeks after gene transfer. 
Results: There were significantly less ratio of intima ares (IA)/media area (MA) and 
higher neointima cell density in stented arteries treated with AdTP_ExR comparing with 
those with AdLacZ. Neither cell replication rate assessed by PCNA immunohistochemis- 
try nor injury score was significantly different between two groups. 
Conclusion: Blockade of TGF-P by local in viva gene transfer of a soluble TGFj3 recep- 
tor inhibits stent-induced neointima by inhibiting ECM accumulation in porcine coronary 
arteries, and may provide a therapeutic potential to inhibit restenosis after stenting. 
Morphometric assessment of stented arteries after gene transfer 
IA/MA MA stem area neointlma cell density 
AdTbExR 0.64*0.44^ 2.2r0.6 mm2 5.4kO.6 mm2 3663i597/mr+ 
AdLacZ 1.21*0.45 1.9+0.6 mm2 5.6+0.7 mm2 2600+190/m& 
‘pcO.05 vs AdLacZ 
1201-119 Adenovirus Mediated Prostacyclin Synthase Gene 
Transfer Inhibits Neointimal Formation by Modulating 
Peroxisome Proliferator-Activated Receptors 
Expression 
Haiime lmai Yasushi Numaguchl, Yasuhiro Nishimoto, Hldeo Matsui, Toyoaki Murohara, 
Kenji Okumura, Nagoya University, Nagoya, Japan, Children’s Hospital, Boston, MA 
Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors 
which regulate cell growth and differentiation by modulating gene transcnption. Many 
data demonstrate that PPARa and y are expressed in human atherosclerotic lesion and 
their ligands like fibrates and troglidazone reduce neointimal formation after angioplasty 
However, little is known about the role of PPARu in regulatory mechanism of arterial 
remodekng. Prostacyclin (PGh) is a potent ligand of PPARa and we have shown that 
PGI, synthase (PCS) gene transfer accelerates reendothelialization through induction of 
cyclooxygenase-2 and vascular endothelial growth factor (VEGF) and prevents neointi- 
mal formation in balloon-injured arteries. To further explore pathophysiological relation- 
ship between PGI, overproduction and PPARa expression in balloon-injured arteries, we 
carried out chronospatial analysis of PPARs &, y and s ) and evaluated arterial mor- 
phometry aHer adenovirus-mediated PCS gene transfer(AdPCS). lmunohistochemical 
analysis revealed that 1)PPARa was positive in endothelium in balloon-injured groups, 
2)all PPAR subtypes were expressed in neointimal area at day 7 and 14, while little was 
found in uninjured vessels, 3)ln AdPCS group, PPAFG and ydistribution was limited to 
the neointima adjacent to endothelium, while, III control, diffuse expression was seen in 
whole neointima. The concentration of tissue 6.keto-ProstaglandinF,,, a metabolite of 
PGh, was significantly increased in AdPCS group (AdPCS vs control; 5.35+/-0.95 vs 
2.29+/-0.54 ngimg tissue, p=O.O2). Morphometric analysis at day 14 revealed that 
AdPCS reduced cntimalmedia ratio up to 40% (AdPCS vs control; 0.63+/-0.05 vs 1.32+/- 
0.13, p=O.Ol). In conclusion, PCS gene transfer could inhibit neointimal formation by 
suppressing smooth muscle cell proliferation and migration partly via PPARs pathway as 
well es acceleration of reendothelialization via cycloorygenase-2.VEGF pathway. 
1201-120 Inhibition of Angiogenesis and Wound Healing by 
Adenovirus-Mediated Gene Transfer of a Soluble Form 
of Vascular Endothelial Growth Factor Receptor in Mice 
Johannes Jacobi Betty Y. Tam, Uma Sundram. Calvin J. Kuo, John P. Cooke, Stanford 
University, Stanford, CA 
Background: Vascular endothelial growth factor (VEGF) is an important angiogenlc 
growth factor. Since anglogenesis plays a major role in wound repair, we hypothesized 
that adenovirus-mediated gene transfer of a soluble form of VEGF receptor 2 (Flk-1) 
might attenuate wound healing in mice. 
